Previous research found that CFL1/Cofilin‐1 expression was significantly increased in AD patients and living skin–equivalent (LSE) models, which were caused by mutations or downregulation of filaggrin, a key epidermal barrier protein.16 This evidence concerns the gene CFL1 and Alzheimer disease.